• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Analysis of p3-Alc peptides, the novel biomarker for Alzheimer's disease

Research Project

  • PDF
Project/Area Number 24790062
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Biological pharmacy
Research InstitutionHokkaido University

Principal Investigator

HATA Saori  北海道大学, 薬学研究科(研究院), 助教 (40581012)

Project Period (FY) 2012-04-01 – 2014-03-31
Keywordsアルツハイマー病
Research Abstract

Alzheimerz's disease (AD) is the most common senile dementia. However, the pathogenesis of AD remains unclear. Moreover, early detection methods and fundamental therapeutic methods for AD are not fully established.
In this study, I detected p3-Alc peptides from CSF samples and plasma samples of AD patients. Our results suggest that alternative processing of multiple gamma-secretase substrates may occur in some AD patients. These finding raise the possibility that the molecular pathogenesis of AD might involve gamma-secretase dysfunction. Measurement of p3-Alc levels may be useful in selecting subjects that might benefit from patient-specific therapy aimed at modulation of gamma-secretase function.

  • Research Products

    (13 results)

All 2014 2013 2012 Other

All Journal Article (7 results) (of which Peer Reviewed: 7 results) Presentation (5 results) Remarks (1 results)

  • [Journal Article] Increased levels of plasma p3-Alcα35, a major fragment of Alcadeinαbyγ-secretase cleavage, in Alzheimer's disease2014

    • Author(s)
      Omori, C., Kaneko, M., Nakajima, E., Akatsu, H., Waragai, M., Maeda, M., Morishima-Kawashima, M., Saito, Y., Nakaya, N., Taru, H., Yamamoto, T., Asada, T., Hata S., Suzuki T., J-ADNI
    • Journal Title

      J. Alzheimer Dis

      Volume: 39 Pages: 861-870

    • DOI

      10.3223/JAD-131610

    • Peer Reviewed
  • [Journal Article] Mechanism of intramembrane cleavage of Alcadeins by?-secretase2013

    • Author(s)
      Piao, Y., Kimura, A., Urano, S., Saito, Y., Taru, H., Yamamoto, T., Hata, S., Suzuki, T
    • Journal Title

      PLoS ONE

      Volume: 8 Pages: e62431

    • DOI

      10.1371/journal.pone.0062431

    • Peer Reviewed
  • [Journal Article] Constitutive cleavage of the single-pass transmembrane protein Alcadeinαprevents aberrant peripheral retention of Kinesin-12012

    • Author(s)
      Maruta, C., Saito, Y., Hata, S., Gotoh, N., Suzuki, T., Yamamoto, T
    • Journal Title

      PLoS ONE

      Volume: 7 Pages: e43058

    • DOI

      10.1371/journal.pone.0043058

    • Peer Reviewed
  • [Journal Article] Membrane-microdomain localization of amyloid?-precursor protein (APP) C-terminal fragments is regulated by phosphorylation of cytoplasmic Thr668 residue2012

    • Author(s)
      Matsushima, T., Saito, Y., Eliott, J. E., Iijima-Ando, K., Nishimura, M., Kimura, N., Hata, S., Yamamoto, T., Nakaya, T., Suzuki, T
    • Journal Title

      J. Biol. Chem

      Volume: 287 Pages: 19715-17924

    • DOI

      10.1074/jbc.M111.334847

    • Peer Reviewed
  • [Journal Article] Multiple?-secretase product peptides are coordinately increased in concentration in the CSF of a subpopulation of sporadic Alzheimer's disease subjects2012

    • Author(s)
      Hata, S., Taniguchi, M., Piao, Y., Ikeuchi, T., Fagan, A. M., Holtzman, D. M., Bateman, R., Gandy, S., Urakami, K., Suzuki, T., J-ADNI
    • Journal Title

      Mol. Neurodegener

      Volume: 7 Pages: 16

    • DOI

      10.1186/1750-1326-7-16

    • Peer Reviewed
  • [Journal Article] Utility of plasma levels of soluble p3-Alcadeinαas a biomarker for sporadic Alzheimer's disease2012

    • Author(s)
      Kamogawa, K., Kohara, K., Tabara, Y., Takita, R., Miki, T., Konno, T., Hata, S., Suzuki, T
    • Journal Title

      J. Alzheimer Dis

      Volume: 31 Pages: 421-428

    • DOI

      10.3233/JAD-2012-120601

    • Peer Reviewed
  • [Journal Article] Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice

    • Author(s)
      Waragai, M., Hata, S., Suzuki, T., Ishii, R., Fujii, C., Tokuda, T., Arai, A., Ohrui, T., Higuchi, S., Yoshida, M., Igarashi, K., Moriya, M., Iwai, N., Uemura, K
    • Journal Title

      J. Alzheimer Dis

      Volume: (in press)

    • Peer Reviewed
  • [Presentation] p3-Alc peptide in the CSF and plasma of sporadic Alzheimer's disease patients2013

    • Author(s)
      Hata, S
    • Organizer
      Society for Neuroscience annual meeting Neuroscience 2013
    • Place of Presentation
      San Diego, USA
    • Year and Date
      20131109-13
  • [Presentation] Function of Alcadein and its metabolite, p3-Alc2013

    • Author(s)
      羽田沙緒里
    • Organizer
      第86回日本生化学会大会
    • Place of Presentation
      横浜
    • Year and Date
      20130911-13
  • [Presentation] Quantitative alteration of p3-Alc peptides in CSF of Alzheimer's disease patients2013

    • Author(s)
      Hata, S
    • Organizer
      Alzheimer's Association International Conference 2013
    • Place of Presentation
      Boston, USA
    • Year and Date
      20130713-18
  • [Presentation] 脳脊髄液・血液診断マーカーとしてのp3-Alcの解析2012

    • Author(s)
      羽田沙緒里
    • Organizer
      第31回日本認知症学会学術集会
    • Place of Presentation
      筑波
    • Year and Date
      20121026-28
  • [Presentation] Increased p3-Alc peptides in the CSF and plasma of sporadic Alzheimer's disease patients2012

    • Author(s)
      Hata, S
    • Organizer
      Alzheimer's Association International Conference 2012
    • Place of Presentation
      Vancouver, Canada
    • Year and Date
      20120714-19
  • [Remarks]

    • URL

      http://www.pharm.hokudai.ac.jp/shinkei/index.html

URL: 

Published: 2015-06-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi